We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The quality unit failed to establish adequate controls to prevent the introduction of microorganisms during the production of sargramostim BDS as evidenced by non-host contamination events.